参考文献 References
[1] 李进. 腹腔镜手术对胆囊结石合并急性胆囊炎患者机体应激及免疫功能的影响[J]. 河北医学, 2017(9).
[2] 任晓萌. 人胆囊炎致病菌对豚鼠肠道屏障及其结构蛋白的影响[D].
[3] 陆磊, 金旭文, 王翬,等. 腹腔镜与开腹胆囊切除术对急性结石性胆囊炎患者肠屏障功能的影响[J]. 中国微创外科杂志, 2018, v.18;No.207(06):49-53.
[4] 高志兴, 杨玉, 徐贵所. 头孢他啶与酪酸梭菌活菌胶囊对急性阑尾炎患者微创术后的胃肠功能的恢复及其对炎症因子水平的影响[J]. 抗感染药学, 2019, 16(02):122-124.
[5] Li Y, Yi S, Zhu Y, Hahn RG. Volume kinetics of Ringer's lactate solution in acute inflammatory disease[J]. Br J Anaesth, 2018,121(3):574-580.
[6] Li Y, Xiaozhu Z, Guomei R, et al. Effects of vasoactive drugs on crystalloid fluid kinetics in septic sheep[J]. PLoS One, 2017, 12: e0172361.
[7] Wang W, Li Z, Meng Q, Zhang P, et al. Chronic Calcium Channel Inhibitor Verapamil Antagonizes TNF-α- Mediated Inflammatory Reaction and Protects Against Inflammatory Arthritis in Mice[J]. Inflammation, 2016, 39(5): 1624-1634.
[8] Lee YM, Song BC, Yeum KJ. Impact of Volatile Anesthetics on Oxidative Stress and Inflammation[J]. Biomed Res Int, 2015,2015:242709.
[9] 杨学时. WBC计数和血清C-反应蛋白在阑尾炎的诊断及病情评估中的价值[J]. 中国卫生检验杂志, 2019, 029(004):435-437.
[10] 穆庆平, 刘毅, 徐玉珩, 等. 黄芪对全身炎症反应综合征患者肠屏障功能保护作用的临床研究[J]. 中国中医药科技, 2016, 23(2):143-145.
[11] Puleo F, Arvanitakis M, Van GA, et al. Gut failure in the ICU[J]. Semin Respir Crit Care Med, 2011, 32:626-638.
[12] Zhu G, Li Y, Ru G, et al. Comparison of the hemodynamics and dynamics of fluid shift of Ringer's solution before surgery in children and adults[J]. Exp Ther Med, 2017, 13(6):3146-3152.
[13] Lowell JA, Schifferdecker C, Driscoll DF, et al. Posto- perative fluid overload: not a benign problem[J]. Crit Care Med, 1990,18(7):728-733.
[14] Weinberg L, Ianno D, Churilov L, et al. Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenect- omy: A prospective multicentre randomized controlled trial[J]. PLoS One, 2017,12(9):e0183313.
[15] Zhi X, Tao J, Li Z, et al. MiR-874 promotes intestinal barrier dysfunction through targeting AQP3 following intestinal ischemic injury[J]. FEBS Letters, 2014, 588(5): 757-763.
[16] Lau E, Marques C, Pestana D, et al. The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity[J]. Nutr Metab (Lond), 2016,13:31.
[17] Earley ZM, Akhtar S, Green SJ, et al. Burn Injury Alters the Intestinal Microbiome and Increases Gut Permeability and Bacterial Translocation[J]. PLoS ONE, 2015, 10:e0129996.
[18] Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability--a new target for disease prevention and therapy[J]. BMC Gastroenterol, 2014,14:189.
[19] Yoseph BP, Klingensmith NJ, Liang Z, et al. Mechanisms of Intestinal Barrier Dysfunction in Sepsis[J]. Shock, 2016,46(1):52-59.
[20] Treskes N, Persoon AM, van Zanten ARH. Diagnostic accuracy of novel serological biomarkers to detect acute mesenteric ischemia: a systematic review and meta-analysis[J]. Intern Emerg Med, 2017,2(6):821-836.
[21] Aquino RS, Teng YH, Park PW. Glycobiology of syndecan-1 in bacterial infections[J]. Biochem Soc Trans, 2018,46(2):371-377.
[22] Yablecovitch D, Oren A, Ben-Horin S, et al. Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease [J]. Dig Dis Sci, 2017,62(3):755-760.
[23] Bertrand J, Bollmann M. Soluble syndecans: biomarkers for diseases and therapeutic options[J]. Br J Pharmacol, 2019,176(1):67-81.
[24] De Haan JJ, Lubbers T, Derikx JP, et al. Rapid d\evelopment of intestinal cell damage following severe trauma: a prospective observational cohort study[J]. Critical Care, 2009, 13(3): R86.
[25] Montagnana M, Danese E, Lippi G. Biochemical markers of acute intestinal ischemia: possibilities and limitations[J]. Ann Transl Med, 2018,6(17):341.
[26] 任晓萌. 人胆囊炎致病菌对豚鼠肠道屏障及其结构蛋白的影响[D]. 2016.
[27] Jones C, Badger SA, Regan M, et al. Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v[J]. Eur J Gastroenterol Hepatol, 2013,25(12):1424-1430.